PFENDO : Ovarian Blockade During Fertility Preservation in Patients With Endometriosis: a Retrospective Non-inferiority Comparative Study
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
The aim of the study is to demonstrate the non-inferiority of dienogest on the number of mature oocytes collected compared with conventional ovarian stimulation protocols (using a GnRH agonist or antagonist), in patients with endometriosis in a fertility preservation context.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 42
View:
• Patient aged between 18 and 42 inclusive
• Patient with endometriosis
• Patient who has undergone at least one cycle of ovarian stimulation for fertility preservation between June 2022 and September 2023 inclusive, using one of the protocols studied:
⁃ GnRH agonist GnRH antagonist Dienogest
Locations
Other Locations
France
CHU de Nîmes
RECRUITING
Nîmes
Time Frame
Start Date: 2023-12-18
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 300
Treatments
dienogest
GnRH agonist
GnRH antagonist
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Universitaire de Nīmes